Molecule Structure

Scientific Name

Erlotinib

Description of the Drug

Erlotinib is an EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00530

Brand Name(s)

Tarceva

Company Owner(s)

Teva Pharmaceuticals Usa Inc, Msn Laboratories Private Ltd, Apotex Inc, Alembic Pharmaceuticals Ltd, Osi Pharmaceuticals Llc, Sun Pharmaceutical Industries Ltd, Shilpa Medicare Ltd, Natco Pharma Ltd, Eugia Pharma Specialities Ltd, Accord Healthcare Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Epidermal growth factor receptor erbB1 SINGLE PROTEIN INHIBITOR CHEMBL203

Unichem Links

SureChEMBL SCHEMBL8413
PharmGKB PA134687924
Human Metabolome Database HMDB0014671
DrugBank DB00530
PubChem: Thomson Pharma 14878691
PubChem 176870
Mcule MCULE-7764565391
LINCS LSM-1097
Nikkaji J910.423B
PDBe AQ4
BindingDB 5446
EPA CompTox Dashboard DTXSID8046454
DrugCentral 1045
Brenda 6877 127378 50296
ChemicalBook CB9285914
Guide to Pharmacology 4920
rxnorm ERLOTINIB TARCEVA ERLOTINIB HYDROCHLORIDE
ChEBI 114785
ZINC ZINC000001546066